CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 5.45
+0.33 (6.45%)
Aug 20, 2026, 4:09 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 8.71 billion as of August 20, 2026. Its market cap has decreased by -32.03% in one year.
Market Cap
8.71B
Enterprise Value
8.03B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.45
ChartMarket Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 8.71B, a decrease of -31.17%. That is a compound annual growth rate of -4.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 8.71B | 12.13% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 11.04B |
| TenNor Therapeutics (Suzhou) | 10.73B |
| Everest Medicines | 10.29B |
| Shaanxi Micot Pharmaceutical Technology | 10.06B |
| Suzhou Ribo Life Science | 8.84B |
| CARsgen Therapeutics Holdings | 8.74B |
| LongBio Pharma (Suzhou) | 8.51B |
| Alphamab Oncology | 8.09B |